2012 ICD-9-CM Diagnosis Codes 209.* : Neuroendocrine tumors A benign or malignant neoplasm composed of cells of neuroendocrine origin.
A neoplasm composed of cells of neuroendocrine origin for which the malignancy status has not been established. A tumor derived from cells that release a hormone in response to a signal from the nervous system. Some examples of neuroendocrine tumors are carcinoid tumors, islet cell tumors, medullary thyroid carcinoma, and pheochromocytoma.
ICD-9-CM 153.9 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 153.9 should only be used for claims with a date of service on or before September 30, 2015.
209.30 is a legacy non-billable code used to specify a medical diagnosis of malignant poorly differentiated neuroendocrine carcinoma, any site. This code was replaced on September 30, 2015 by its ICD-10 equivalent. Primitive neuroectodermal tumor
209.30 is a legacy non-billable code used to specify a medical diagnosis of malignant poorly differentiated neuroendocrine carcinoma, any site. This code was replaced on September 30, 2015 by its ICD-10 equivalent.
The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.
ICD-9-CM 153.9 is a billable medical code that can be used to indicate a diagnosis on a reimbursement claim, however, 153.9 should only be used for claims with a date of service on or before September 30, 2015. For claims with a date of service on or after October 1, 2015, use an equivalent ICD-10-CM code (or codes).
Primary adenocarcinoma of colon. Clinical Information. A primary or metastatic malignant neoplasm involving the colon. A primary or metastatic malignant neoplasm that affects the colon. Representative examples include carcinoma, lymphoma, and sarcoma. Malignant tumor of the colon or rectum.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned. Malignant neoplasm of ectopic tissue. Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, ...
Carcinoid tumors are one subset of tumors called neuroendocrine tumors, usually begin in the digestive tract (stomach, appendix, small intestine, colon, rectum) or in the lungs. When the documentation states only carcinoid tumor and does not provide enough information (site) to assign a more specific code.
C7B.1. If a neuroendocrine tumor (NET) spreads, it can spread to the below sites and metastasis code should be from C7B series. Carcinoid malignancies aren't going to metastasize as another type of carcinoma. tissues or structures near the organ where the cancer started, such as the peritoneum, the pleura or fat tissue.
Neuroendocrine tumors are a rare type of tumor composed of cells that produce and secrete regulatory hormones.
A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere.
tobacco use ( Z72.0) Malignant neoplasm of nasopharynx. Approximate Synonyms. Cancer of the nasopharynx. Cancer of the nasopharynx, adenocarcinoma. Cancer of the nasopharynx, adenoid cystic. Cancer of the nasopharynx, squamous cell. Cancer of the nasopharynx, undifferentiated. Primary adenocarcinoma of nasopharynx.